Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS Monotherapy for Renal Dysfunction After Liver Transplantation
ChiCTR2500099977Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate sodium in chronic kidney disease (CKD), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Renal function. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
mycophenolate sodium
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2500099977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099977.